Jefferies Reiterates Buy Rating on AC Immune SA (ACIU): '2025 financials largely immaterial'
Tweet Send to a Friend
Jefferies analyst Lucy Codrington reiterated a Buy rating and $7.00 price target on AC Immune SA (NASDAQ: ACIU)The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
